First Time Loading...

Xylem Inc
NYSE:XYL

Watchlist Manager
Xylem Inc Logo
Xylem Inc
NYSE:XYL
Watchlist
Price: 145.77 USD 1.71% Market Closed
Updated: May 21, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

15.9B
-1%
Assets
Growth Rates:
1 Year
+101%
3 Years
+86%
5 Years
+113%
7 Years
+144%
10 Years
+226%
5.7B
-4%
Liabilities
Growth Rates:
1 Year
+31%
3 Years
+2%
5 Years
+23%
7 Years
+34%
10 Years
+116%
10.2B
+0.3%
Equity
Growth Rates:
1 Year
+185%
3 Years
+247%
5 Years
+265%
7 Years
+353%
10 Years
+357%

Balance Sheet Decomposition
Xylem Inc

15.9B
Assets
5.7B
Liabilities
15.9B
Assets
5.7B
Liabilities
Current Assets 3.9B
Cash & Short-Term Investments 947m
Receivables 1.6B
Other Current Assets 1.3B
Non-Current Assets 12B
PP&E 1.1B
Intangibles 10B
Other Non-Current Assets 927m
Current Liabilities 2.3B
Accounts Payable 948m
Accrued Liabilities 575m
Other Current Liabilities 808m
Non-Current Liabilities 3.4B
Long-Term Debt 2B
Other Non-Current Liabilities 1.4B

Balance Sheet
Xylem Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
663
680
308
414
296
724
1 875
1 349
944
1 019
Cash Equivalents
663
680
308
414
296
724
1 875
1 349
944
1 019
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
Total Receivables
771
749
843
956
1 031
1 036
923
953
1 096
1 617
Accounts Receivables
771
749
843
956
1 031
1 036
923
953
1 096
1 617
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
486
433
522
524
595
539
558
700
799
1 018
Other Current Assets
144
143
166
177
172
151
167
158
173
230
Total Current Assets
2 064
2 005
1 839
2 071
2 094
2 450
3 523
3 160
3 012
3 884
PP&E Net
461
439
616
643
656
899
929
948
940
1 602
PP&E Gross
461
439
616
643
656
899
929
948
940
1 602
Accumulated Depreciation
804
800
822
933
976
1 044
1 157
1 182
1 157
1 298
Intangible Assets
470
435
1 201
1 168
1 232
1 174
1 093
1 016
930
2 529
Goodwill
1 635
1 584
2 632
2 768
2 976
2 839
2 854
2 792
2 719
7 587
Other Long-Term Assets
203
194
186
210
264
348
351
360
351
510
Other Assets
1 635
1 584
2 632
2 768
2 976
2 839
2 854
2 792
2 719
7 587
Total Assets
4 833
N/A
4 657
-4%
6 474
+39%
6 860
+6%
7 222
+5%
7 710
+7%
8 750
+13%
8 276
-5%
7 952
-4%
16 112
+103%
Liabilities
Accounts Payable
338
338
457
549
586
597
569
639
723
968
Accrued Liabilities
320
279
378
356
331
396
498
480
471
659
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
89
78
260
0
257
276
600
0
0
38
Other Current Liabilities
156
128
143
195
215
232
289
272
396
540
Total Current Liabilities
903
823
1 238
1 100
1 389
1 501
1 956
1 391
1 590
2 205
Long-Term Debt
1 195
1 196
2 108
2 200
2 051
2 040
2 484
2 440
1 880
2 332
Deferred Income Tax
136
118
352
252
303
310
242
287
222
557
Minority Interest
0
0
17
16
14
10
8
8
9
10
Other Liabilities
472
436
569
789
697
892
1 092
932
757
842
Total Liabilities
2 706
N/A
2 573
-5%
4 284
+66%
4 357
+2%
4 454
+2%
4 753
+7%
5 782
+22%
5 058
-13%
4 458
-12%
5 946
+33%
Equity
Common Stock
2
2
2
2
2
2
2
2
2
3
Retained Earnings
648
885
1 033
1 227
1 639
1 866
1 930
2 154
2 292
2 601
Additional Paid In Capital
1 796
1 834
1 876
1 912
1 950
1 991
2 037
2 089
2 134
8 564
Treasury Stock
220
399
403
428
487
527
588
656
708
733
Other Equity
99
238
318
210
336
375
413
371
226
269
Total Equity
2 127
N/A
2 084
-2%
2 190
+5%
2 503
+14%
2 768
+11%
2 957
+7%
2 968
+0%
3 218
+8%
3 494
+9%
10 166
+191%
Total Liabilities & Equity
4 833
N/A
4 657
-4%
6 474
+39%
6 860
+6%
7 222
+5%
7 710
+7%
8 750
+13%
8 276
-5%
7 952
-4%
16 112
+103%
Shares Outstanding
Common Shares Outstanding
182
178
180
180
180
180
180
180
180
242

See Also

Summary
XYL intrinsic value, competitors valuation, and company profile.
DCF Valuation
XYL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XYL stock valuation using valuation multiples.
Wall Street Estimates
XYL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XYL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.